--- a
+++ b/clusters/3009knumclusters/clust_17.txt
@@ -0,0 +1,424 @@
+Hemoglobin (Hgb) >= 9 g/dl
+Hemoglobin (Hgb) > 8.0 g/dL =< 2 weeks prior to randomization
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable); obtained within 14 days prior to study entry
+Must have hemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.
+Hgb ? 10 g/dL
+Hemoglobin (HGB) > 8.0 gm/dl
+Hemoglobin (Hgb) >= 8 g/dL (with or without transfusion support)
+Hemoglobin (Hgb) > 9.0 g/dL, must be obtained within 8 weeks prior to screening for protocol therapy
+ELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP 1): Hemoglobin (Hgb) > 9.0 g/dL
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin (HgB) >= 9.0 gr/dL
+Within 60 days prior to registration on study: Hemoglobin (Hgb) >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)
+Within 14 days prior to registration: Hemoglobin (Hgb) >= 8 g/dl
+Hemoglobin >= 10.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is NOT allowed)
+Hemoglobin (Hgb) > 9.0 g/dL obtained =< 21 days prior to registration
+Hemoglobin >= 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 10.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl, within 21 days prior to registration (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin >= 10.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable), within 21 days prior to study entry
+Hemoglobin (Hgb) >= 8.5
+Obtained within 14 days prior to treatment start: Hemoglobin (HGB) >= 9 g/dl
+Hemoglobin (HGB) >= 8 g/dL, within 14 days of registration
+Hemoglobin (Hgb) >= 8 g/dl
+Hemoglobin (Hgb) ? 8 g/dL
+Hemoglobin (Hgb) >= 9 g/dL obtained within 14 days prior to registration
+Procurement: Hemoglobin (Hgb) > 8.0 g/dl (transfusions allowed)
+Patients with Hgb > 8.0 g/dl (transfusion allowed)
+Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) < 9 g/dL without growth factor or transfusion support
+Hemoglobin (Hgb) ? 80 g/L
+Hemoglobin (Hgb) < 9 g/dL
+Hemoglobin (Hgb) ? 9 g/dL;
+Hgb-A1C ? 7.5%;
+Hemoglobin (Hgb) > 10 g/dL within 14 days of starting cycle 1 day 1 treatment
+Hgb < 10 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dl
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (HGB) >= 9 g/dL
+Hemoglobin (HGB) > 8.0 gm/dL (patients may be transfused to achieve this HGB level);
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+PROCUREMENT: Hemoglobin (Hgb) > 8.0 (transfusions allowed)
+TREATMENT: Hgb > 8.0 g/dL (transfusions allowed)
+Hemoglobin (HgB) > 8.0
+Hemoglobin (Hgb) > 8.0
+Hemoglobin (Hgb) ? 8.0 g/dL, stable for ? 1 week
+Hgb > 8.0 (transfusion allowed)
+INCLUSION - PROCUREMENT: Hemoglobin (Hgb) > 8.0 (can be transfused)
+At least one cytopenia (ANC < 1800/µL or platelet count < 100,000/µL or hemoglobin [Hgb] < 10 g/dL)
+Hemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable), obtained within 30 days prior to registration
+Hemoglobin (HgB) > 9 g/dL. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.
+INCLUSION - INFUSION: Hemoglobin (Hgb) > 8.0 (may be a transfused value)
+Hemoglobin (Hgb) > 8.0 gm/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Hgb-A1C =< 7.5%
+PROCUREMENT INCLUSION: Hemoglobin (Hgb) > 8.0 (may be a transfused value)
+Hemoglobin (Hgb) >= 9 g/dL (with/without transfusion)
+Hemoglobin >= 10.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 10.0 g/dl is acceptable)
+Hemoglobin (Hgb) > 9 g/dL, at the screening visit
+Hgb ? 9 g/dL
+Glycosylated hemoglobin (Hgb A1c) =< 6.5%
+Hemoglobin (Hgb) >= 10.0 g/dL
+Hemoglobin (Hgb) > 8.0 g/dL (can be transfused)
+Hemoglobin ?9 g/dL (transfused Hgb allowed)
+Hemoglobin (Hgb) > 8.0 g/dL (can be transfused)
+Hemoglobin (Hgb) <9 g/dL
+OBTAINED =< 7 DAYS PRIOR TO REGISTRATION: Hemoglobin (Hgb) >= 9.0 g/dL
+Hgb > 8.0 (transfusion allowed)
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (Hgb) > 9 g/dL.
+Glycated hemoglobin (Hgb-A1C) level of =< 7.5%.
+Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
+Hemoglobin (Hgb) > 8.0 (can be transfused)
+INCLUSION - TREATMENT: Hemoglobin (Hgb) ? 9.0 g/dl
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= g/dl is acceptable)
+Hemoglobin > =10 g/dl. The use of transfusion or other intervention to achieve Hgb ?10.0 g/dl is acceptable.
+Hemoglobin (Hgb) >= 9 g/dL
+Anemia (hemoglobin [Hgb] < 10 g/dL)
+Hemoglobin (Hgb) >= 9 g/dL (acceptable to reach via transfusion) obtained within 14 days prior to initiating study treatment.
+Hemoglobin (Hgb) >= 9 g/dL.
+Hemoglobin (Hgb) >= 8.5 g/dl
+Hemoglobin (Hgb) < 8 mg/dl, per PI discretion if thought to be related to underlying myeloma
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (HgB) >= 9 g/dL compatible for surgery
+Obtained =< 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (HgB) < 10 g/dL
+Hemoglobin (Hgb) >= 9 g/dL (more than 48 hours post-completion of blood transfusion)
+Obtained within 28 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
+Within 28 days prior to registration: Hemoglobin (Hgb) >= 10 g/dL
+Hemoglobin (Hgb) >= 9 g/dL (in absence of blood transfusion).
+Hemoglobin (Hgb) > 8 g/dL
+Hemoglobin (Hgb) ? 9.0 g/dL
+Hemoglobin (Hgb) =< 10.0 or
+Hemoglobin (Hgb) > 7.5 gm/dL
+Obtained within 28 days prior to registration: hemoglobin (Hgb) >= 8.0 g/dl; Note: The use of transfusion or other intervention to achieve Hgb >= 8.0 g/dl is acceptable
+Within 4 weeks of day 1: Hemoglobin (HgB) >= 10.0 gr/dL independent of transfusion
+Hemoglobin (Hgb) ? 9 g/dL obtained ? 14 days prior to randomization; patient may receive transfusion as needed
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL.
+Hemoglobin (Hgb) < 8 mg/dl
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L without (w/o) transfusion within 7 days of assessment.
+Hemoglobin (Hgb) >= 9 g/dL; (last transfusion cannot be within 7 days of trial initiation)
+Hemoglobin (Hgb) >= 9 g/dL (within 16 days before starting therapy)
+Hgb >= 10 g/dL ((within 16 days before starting therapy)
+Hemoglobin (HGB) >= 10 g/dl
+HGB of > 10 g/L
+Hemoglobin (Hgb) > 8.0 g/dL
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin >= 8.0 g/dl; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptable
+Hemoglobin (Hgb) >= 10 g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)
+Within 14 days prior to cycle 1 day 1 of treatment: Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 9 g/dl
+Hemoglobin (HGB) > 9.0 g/dL, within 30 days before study registration
+Hemoglobin (Hgb) >= 9.0 g/dL
+Within 4 weeks prior to the registration: hemoglobin >= 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) > 8.0 gm/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (HGB) >= 7 g/dl without transfusion or growth factor support for at least 1 week
+Hemoglobin (Hgb) >= 10 g/dl within 30 days of enrollment to study
+Hemoglobin (Hgb) >= 9 g/dL (obtained within 28 days prior to first study treatment)
+Hemoglobin (Hgb) > 8.5 g/dL
+Hemoglobin (Hgb) > 9.0 g/dL, within 14 days prior to treatment
+Hemoglobin (Hgb) >= 9 g/dL.
+Hemoglobin (Hgb) >= 9 g/dL, within 14 days start of study start
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) ? 9 g/dL
+Hemoglobin (Hgb) >= 10 g/dL; eligibility level for hemoglobin may be reached by transfusion, within 14 day prior to registration
+Hemoglobin (HGB) < 8 g/dL
+Hemoglobin (Hgb) >= 9.0 gm/dl
+Hemoglobin (Hgb) >= 8 gr/dL
+Hemoglobin (Hgb) >= 9 g/dL
+EXCLUSION CRITERIA FOR PATIENTS WITH NSCLC OR TNBC (COHORT B): Hemoglobin (Hgb) < 9 mg/dl (transfusion permitted to achieve this)
+Obtained =< 14 days prior to registration: Hemoglobin (HgB) >= 9.0 g/dL
+PRIOR TO CELL PROCUREMENT: Hemoglobin (Hgb) ? 8.0 g/dL (transfusion independent for 2 weeks prior to enrollment)
+Hemoglobin (Hgb) > 8 g/dl
+Hemoglobin (Hgb) >= 9 g/dL without transfusions
+Hemoglobin (Hgb) ? 90 g/L (9 g/dL).
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (HgB) >= 9.0 g/dL
+Within 14 days prior to registration: Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 8 g/dL
+Hgb ?10 g/dL - can be transfused
+Within 3 months of registration: Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL (transfusions allowed)
+Hgb ? 9 g/dL
+Within 14 days prior to study entry: Hemoglobin (Hgb) > 9.0 g/dL (with or without transfusion)
+Within 6 weeks of day 1: Hemoglobin (HgB) >= 9.0 gm/dL
+Hemoglobin (Hgb) > 10 within 30 days of consent
+Hemoglobin (Hgb) > 9 within 45 days of consent
+Hemoglobin (Hgb) >= 10.0 gm/dl within 14 days of study entry
+Hemoglobin (HgB) >= 9 g/dL
+AT THE TIME OF INFUSION: Hemoglobin (Hgb) ? 8.0
+Hemoglobin (Hgb) >= 9 g/dL
+TREATMENT: Hemoglobin (Hgb) > 8.0 g/dL
+Hemoglobin (HGB) >= 9 g/dl (please note: it is acceptable from the standpoint of study eligibility to undergo transfusion in order to achieve hemoglobin >= 9 g/dl)
+Hemoglobin (Hgb) <9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 8
+PROCUREMENT: Hemoglobin (Hgb) > 8.0 (transfusions allowed)
+TREATMENT: Hgb > 8.0 (transfusion allowed)
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) > 8.0 (may be transfused).
+Hemoglobin (Hgb) >= 9 g/dl, obtained =< 14 days prior to registration
+Hemoglobin (Hgb) greater than 10 g/L
+Within 2 weeks of enrollment: Hemoglobin >= 10 g/dl; (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10 g/dl is acceptable)
+Hemoglobin (Hgb) > 9 g/dL
+Within 30 days of first vaccination: Hemoglobin (Hgb) >= 10 g/dl
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (HgB) > 8.0
+Hemoglobin (Hgb) >= 9.0 g/dL (obtained =< 7 days prior to registration)
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 9
+Hemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= g/dl is acceptable)
+Hemoglobin (Hgb) >= 9 g/dL
+Within 14 days prior to registration: Hemoglobin (Hgb) >= 9.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 9.0 is acceptable)
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hgb > 8.0
+Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 10 g/dl
+Hemoglobin >= 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
+Hemoglobin >= 8 g/dl (Note: the use of transfusion to achieve hemoglobin [Hgb] >= 8 g/dl is acceptable)
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 8.5 g/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 10 g/dl
+Hemoglobin (HGB) >= 9 g/dL
+Hemoglobin (Hgb) > 8.0 (may be a transfused value)
+Hemoglobin (Hgb) >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)
+At least one laboratory abnormality probably or definitely attributed to KSHV-MCD\r\n* Anemia (hemoglobin [Hgb] [men] =< 12.5 gm/dL, Hgb [women] =< 11 gm/dL)\r\n* Thrombocytopenia (=< 130,000/mm^3)\r\n* Hypoalbuminemia (< 3.4 g/dL)
+Hemoglobin (Hgb) < 8 g/dL
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] > 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) > 8.0
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dl
+Hemoglobin (Hgb) >= 9 g/dl
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (HgB) > 9.0 g/dL; NOTE: subjects may not have had a transfusion within 7 days of registration
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Within 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (HgB) >= 9 g/dL for mono-therapy
+Hemoglobin (Hgb) >= 9 g/dL without transfusions
+Hemoglobin (Hgb) ? 9 g/dL
+Hemoglobin (Hgb) ? 9 g/dL
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin (Hgb) less than or equal to 8 g/dL
+Hemoglobin (Hgb) > 8 g/dL
+To be performed within 28 days prior to day 1 of protocol therapy: Hemoglobin (Hgb) >= 8 g/dL without transfusions
+Hemoglobin >= 9.0 g/dl; (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
+Within 14 days prior to step 1 registration: Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
+Hemoglobin: >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 8 g/dL, obtained within 14 days prior to registration for protocol therapy
+Hemoglobin (HgB) > 9.0 g/dL
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Obtained within 30 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) < 9 g/dL
+Hemoglobin >= 9.0 g/dL (patients may be transfused to meet hemoglobin [Hgb] requirement)
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) >= 9.0 gm/dL
+Hemoglobin >= 10.0 mg/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
+Hemoglobin (Hgb) > 10
+Hemoglobin >= 8.0 g/dl; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptable; within 14 days prior to registration
+Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl (NOTE: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)
+Hemoglobin (Hgb) >= 8.0 g/dL
+Hemoglobin (Hgb) >= 8 g/dl (transfusion acceptable)
+Hemoglobin (Hgb) >= 10.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 10.0 g/dL is acceptable)
+Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 9.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 9.0 g/dL is acceptable)
+Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)
+Hemoglobin (Hgb) >= 9.0 g/dL (transfusions allowed)
+Hemoglobin >= 10.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 10.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 9.0 g/dl
+Hemoglobin (Hgb) > 8.0
+Anemia (hemoglobin [Hgb] < 10 g/dL)
+HGB ?10 g/dl and not transfusion dependent
+Hemoglobin (Hgb) ? 90 g/L,
+Hemoglobin (Hgb) ? 9.0 g/dL
+Hemoglobin (Hgb) >= 8.0 g/dL (transfusion or other intervention to achieve Hgb >= 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hgb > 9 g/dL
+Hemoglobin (Hgb) ? 9 g/dL
+Hemoglobin (Hgb) ? 9 g/dl
+Hemoglobin (HgB) > 9 g/dL (acceptable to reach this by transfusion)
+Hemoglobin >= 8.0 g/dl (Note: use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) ? 9 g/dL.
+Hgb ?9 g/dL
+Hemoglobin (Hgb) ? 9 g/dl
+Hemoglobin (HgB) >= 9
+Within 14 days of study start: Hemoglobin (Hgb) >= 9 g/dL (may transfuse if clinically indicated)
+Hemoglobin (Hgb) > 9 g/dL (can be achieved with transfusion)
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) > 8.0 g/dL
+Hemoglobin (Hgb) > 8.0
+Hemoglobin >= 10.0 g/dL (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8 g/dl is acceptable)
+Hemoglobin (Hgb) >= 8 gm/dL (transfusion independent)
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (HgB) ?9 g/dL.
+Hemoglobin (Hgb) >= 9.0 g/dL (no red blood cell [RBC] transfusion within past 14 days)\r\n* Hgb >= 8.0 g/dL for patients with anemia associated disease
+Glycosylated hemoglobin (Hgb A1C) > 8.0%
+Hemoglobin (Hgb) >= 10 g/dL (within 16 days before starting therapy)
+Hemoglobin (Hgb) > 9
+Hemoglobin (Hgb) > 9 g/dl
+Obtained within 14 weeks prior to registration on study: hemoglobin >= 8.0 g/dl (the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) > 9.0 g/dL obtained within 14 days prior to registration
+Hemoglobin (Hgb) >= 9 g/dL (which may be post transfusion)
+Hemoglobin (Hgb) greater than or equal to 9 g/dL
+Hemoglobin (HGB) >= 10 g/dl
+Hemoglobin (Hgb) >= 9.5 g/dL (transfusion before treatment is allowable if more than 3 days prior to study start)
+Hemoglobin (Hgb) > 10 g/dL
+Hemoglobin (Hgb) > 10 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL (90 g/L) without blood transfusion within 7 days
+Hemoglobin >= 10 g/dl based on CBC/differential obtained within 21 days prior to study registration (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)
+Hemoglobin (HgB) >= 10.0 g/dL
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (Hgb) greater than or equal to 9 g/dL (transfusions are allowed)
+AT THE TIME OF INFUSION: Hemoglobin (Hgb) > 8.0g/dl (can be transfused)
+Hemoglobin (Hgb) >= 9.0 g/dL
+hemoglobin (Hgb) > 9.9 g/dL
+Hemoglobin (Hgb) A1C =< 8%
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin >= 8.0 g/dl within 30 days prior to registration; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptable
+Hemoglobin (HGB) >= 8 g/dL
+Hemoglobin (Hgb) >= 10 g/dl
+Hemoglobin (Hgb) >= 9 gm/dL
+Hemoglobin (Hgb) >= 10 g/dL (within 16 days before starting therapy)
+Hemoglobin (Hgb) >= 8 g/dl
+Hemoglobin (Hgb) >= 8.5 g/dL
+Hemoglobin (Hgb) >8.0gm/dL
+Obtained within 2 weeks from study entry: Hemoglobin (HgB) >= 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dl
+Hemoglobin (Hgb) ? 10 g/dl
+Hemoglobin (Hgb) ? 10 g/dl.
+Hemoglobin (Hgb) ? 9.0 g/dL
+Hemoglobin (Hgb) < 7.0
+Obtained =< 7 days prior to registration: Hemoglobin (Hgb) > 9.0 mg/dl
+Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 9.0 g/dl
+Hemoglobin (hgb) =< 10.0 or
+Hemoglobin (HgB) >= 9.0 mg/dL
+Hemoglobin (Hgb) >= 9 gm/dL (unless due to bone marrow infiltration by tumor in which case Hgb > 8 gm/dL)
+Hemoglobin (Hgb) > 8.0 g/dl
+Hemoglobin (Hgb) >= 10 g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)
+Hemoglobin (Hgb) >= 9 mg/dL (which may be post transfusion)
+Hemoglobin (Hgb) >= 9 g/dL may be supported by transfusion and/or hematopoetic growth factors
+Hemoglobin (Hgb) >= 9g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL (transfusion allowed), within 14 days of registration
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dl
+Hemoglobin (HGB) >= 8 gm/dL
+Hemoglobin (Hgb) ? 9.0 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin ? 8.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ?8.0 g/dl is acceptable).
+Hemoglobin (Hgb) > 8.0
+Hemoglobin >= 8.0 g/dl (NOTE: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 9 g/dL without transfusions
+Hemoglobin (Hgb) ? 9 g/dL.
+Hemoglobin >= 9.0 g/dl; (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
+Hemoglobin (Hgb) < 9 g/dL
+Participants requiring blood transfusions to maintain hemoglobin (Hgb) eligibility
+Hemoglobin (Hgb) ?10 g/dL
+Hemoglobin (HgB) > 9.0 g/dL
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) >= 10 g/dL
+Hemoglobin (Hgb) >= 10 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dl
+Hemoglobin (Hgb) ? 9.0 g/dL
+SELUMETINIB ARM: Hemoglobin (Hgb) < 9.0 g/dL
+Hemoglobin (HgB) >= 8.0 g/dL
+Hemoglobin (Hgb) >= 9 g/L
+Hemoglobin (Hgb) >= 10 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+HgB < 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (HgB)>8.0 (may be transfused)
+Hemoglobin (Hgb) >= 9 g/dL
+HGB >9.0 g/dL
+Hemoglobin (Hgb) ? 9.0 g/dL;
+Hemoglobin (Hgb) ? 9 g/dL.
+Hemoglobin (HgB) >= 9 g/dL
+Hemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion within 1 week of baseline Hgb assessment.
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 9 g/dL without transfusions
+Does the subject have a Hgb ? 10 g/dL?
+Hemoglobin (Hgb) ? 9 g/L
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL
+Hemoglobin (Hgb) >= 9.0 g/dL obtained =< 7 days prior to registration
+Hemoglobin (Hgb) ? 9 g/dL.
+Hgb > 7.5 g/dl (without transfusion within 7 days)
+Hemoglobin (Hgb) ? 8.0 g/dL at Baseline (within 24 hours prior to surgical procedure).
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) ? 8.0 g/dL
+Hemoglobin (Hgb) ? 9 g/dL
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (HGB) >= 9 gm/dL
+Hemoglobin (Hgb) >= 10.0 gm/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 10.0 is acceptable)
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (HgB) > 8.5 g/dL
+Hemoglobin (Hgb) ?9.5 g/dl
+Hemoglobin (Hgb) A1C =< 8%
+Hemoglobin (Hgb) A1C =< 8%
+Hemoglobin (HgB) > 9.0 g/dL
+Bone marrow: Absolute Neutrophil Count (ANC) ? 1.5 x 109/L, Hemoglobin (Hgb) ? 9 g/dL, Platelets ? 100 x 109/L
+Hemoglobin (Hgb) >= 9.0 g/dl
+Hemoglobin (Hgb) > 9.0 gms/dl
+Hemoglobin (Hgb) > 8.0 g/dl
+Hemoglobin (Hgb) >= 8 g/dL
+Hemoglobin (Hgb) >= 9 g/dL without transfusions
+Hemoglobin (Hgb) > 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
+Hemoglobin >= 10.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
+Hemoglobin ? 9.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ? 9.0 g/dl is acceptable.)
+Evidence of iron deficiency anemia including, hemoglobin (Hgb) < 11 g/dL, but > 8 g/dL; and transferrin saturation (TSAT) < 20%
+Severe anemia with hemoglobin (HGB) < 10
+Subjects who have diabetes with a hemoglobin (Hgb) A1c > 7
+Hemoglobin (Hgb) ? 9.0 g/dL
+Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L
+Hemoglobin (HgB) >= 9.0 g/dL
+Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (Hgb) ?>= 8.0 g/dL
+Hemoglobin (Hgb) >= 9.0
+Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) > 8.0
+Hemoglobin (Hgb) > 8.0 g/dL
+Hgb ? 9 g/dL
+Hemoglobin (Hgb) >= 10 g/dl within 90 days of enrollment
+Hemoglobin (Hgb) >= 8.0g/dL
+Hemoglobin (Hgb) within normal limits for institution/lab
+Hemoglobin (Hgb) ? 8 g/dL.
+Hemoglobin (Hgb) > 10.0 g/dL with no blood transfusion in the past 28 days
+Hemoglobin (Hgb) ? 10 g/dl
+Hemoglobin (Hgb) > 8.0
+Hemoglobin (hgb) ? 8.0 g/dL (may be supported with transfusion)
+Obtained within 28 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
+Hemoglobin (Hgb) >= 9 g/dL (90 g/L); < 9 g/dL (< 90 g/L) is acceptable if Hgb is corrected to >= 9 g/dL (90 g/L) as by growth factor or transfusion prior to PET scan, obtained within 14 days prior to PET scan
+Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L without transfusion or erythropoietin (EPO) dependency (within 7 days of assessment of Hgb), obtained within 14 days prior to C11-AMT PET scan
+Hemoglobin (hgb) > 10 G/dL
+Hemoglobin >= 8.0 g/dl (the use of transfusion or other invention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin >= 8.0 g/dl (The use of transfusion or other invention to achieve Hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
+Hemoglobin (HgB) > 9 mg/dL